PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Future Pharma Services
Putting quality first in the pharma supply chain
Enabling better biopharmaceutical manufacturing
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Small-cap companies lead the oncology pipeline by programmes in development
Generics expected to improve access for patients with idiopathic pulmonary fibrosis
Alvotech’s AVT05 in Phase III rheumatoid arthritis study, as the sole candidate
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Deka Biosciences secures $20m to advance product pipeline
Fabre-Kramer gains FDA approval for major depressive disorder therapy
FAYTEC
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Generative AI-focused biotech startup Evozyne raises $81m
FAYTEC
Ono and Adimab partner to develop oncology antibody drugs
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Leading providers of product inspection, testing and detection equipment and services
Mobile health strategies: Should you build or partner for success?
The competitive edge: Unlocking the full potential of autoinjectors through comprehensive in-house manufacturing
Events
Reports
Premium Insights
Newsletters
PT
All articles by Gustav Ando
Gustav Ando
Analyst Comment
Why are pharma prices changing?
Analyst Comment
Mixed news on COVID19 vaccines: COVID-19 R&D tracker
Analyst Comment
Prices of essential COVID-19 medicines have increased 4% globally since February
Analyst Comment
US scrambles for resources in COVID-19 response
Analyst Comment
ISPOR Europe 2018 Barcelona
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Analyst Comment
Rapid changes in the global IRP environment
Analyst Comment
Nevermore ignore the role of digital health in health decision making
Analyst Comment
ISPOR 2018 Baltimore
Analyst Comment
Visit us at ISPOR 2017 Glasgow!
Analyst Comment
US Healthcare Reform: The ISPOR Debate
View more
Most Popular
Strides Pharma gets FDA greenlight to market HIV treatment
Pfizer’s Hospira issues recall after glass particles found in injectables
Sanofi continues expansion spree by licencing Teva’s IBD drug for $1.5bn
